Document:

REGISTRATION
RIGHTS AGREEMENT

 

THIS
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 25, 2019 (the “Execution
Date”), is entered into by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”),
and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”).
Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity
Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise
modified from time to time, the “Purchase Agreement”).

 

WHEREAS:

 

The
Company has agreed, upon the terms and subject to the conditions of the Purchase Agreement, to sell to the Buyer up to Ten Million
Dollars ($10,000,000.00) of Put Shares and to induce the Buyer to enter into the Purchase Agreement, the Company has agreed to
provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or
any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws.

 

NOW,
THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Buyer hereby agree as follows:

 

1.
DEFINITIONS.

 

As
used in this Agreement, the following terms shall have the following meanings:

 

a.
“Investor” means the Buyer,
any transferee or assignee thereof to whom the Buyer assigns its rights under this Agreement in accordance with Section 9
and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee
or assignee assigns its rights under this Agreement in accordance with Section 9 and who agrees to become bound by the
provisions of this Agreement.

 

b.
“Person” means any individual
or entity including but not limited to any corporation, a limited liability company, an association, a partnership, an organization,
a business, an individual, a governmental or political subdivision thereof or a governmental agency.

 

c.
“Register,” “Registered,”
and “Registration” refer to a registration effected by preparing and filing one or more registration statements
of the Company in compliance with the Securities Act and/or pursuant to Rule 415 under the Securities Act or any successor rule
providing for the offering securities on a continuous basis (“Rule 415”), and the declaration or ordering of
effectiveness of such registration statement(s) by the United States Securities and Exchange Commission (the “SEC”).

 

    	 	1	 

     

    

 

d.
“Registrable Securities” means
all of the Put Shares which have been, or which may, from time to time be issued, including without limitation all of the shares
of Common Stock which have been issued or will be issued to the Investor under the Purchase Agreement (without regard to any limitation
or restriction on purchases), and any and all shares of capital stock issued or issuable with respect to the Put Shares (as such
terms are defined in the Purchase Agreement) issued or issuable to the Investor, and shares of Common Stock issued to the Investor
with respect to the Put Shares and the Purchase Agreement as a result of any stock split, stock dividend, recapitalization, exchange
or similar event or otherwise, without regard to any limitation on purchases under the Purchase Agreement.

 

e.
“Registration Statement” means
one or more registration statements of the Company covering only the sale of the Registrable Securities.

 

2.
REGISTRATION.

 

a.
Mandatory Registration. The Company shall,
by March 1, 2019, file with the SEC an initial Registration Statement on Form S-1 covering the maximum number of Registrable Securities
as shall be permitted to be included thereon (in such amounts as to the specific Registrable Securities included therein as mutually
identified by the Investor, the Company and their respective legal counsel) in accordance with applicable SEC rules, regulations
and interpretations so as to permit the resale of such Registrable Securities by the Investor, including but not limited to under
Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices), as mutually determined by both the
Company and the Investor in consultation with their respective legal counsel (the “Initial Registration Statement”).
The Initial Registration Statement shall register only the Registrable Securities. The Company shall use its commercially reasonable
best efforts to have the Initial Registration Statement and any amendment thereto declared effective by the SEC at the earliest
possible date (in any event, within one hundred fifty (150) calendar days after the Execution Date).

 

b.
Rule 424 Prospectus. In addition to the
Initial Registration Statement, the Company shall, as required by applicable securities regulations, from time to time file with
the SEC, pursuant to Rule 424 promulgated under the Securities Act, such prospectuses and prospectus supplements to be used in
connection with sales of the Registrable Securities under each Registration Statement. The Investor and its counsel shall have
a reasonable opportunity to review and comment upon such prospectuses prior to its filing with the SEC, and the Company shall
give due consideration to all such comments. The Investor and its counsel shall use their reasonable best efforts to comment upon
any prospectus within two (2) business days from the date the Investor receives the final pre-filing version of such prospectus.

 

c.
Sufficient Number of Shares Registered.
In the event the number of shares available under the Initial Registration Statement is insufficient to cover all of the Registrable
Securities, the Company shall amend the Initial Registration Statement or file a new Registration Statement (a “New Registration
Statement”), so as to cover all of such Registrable Securities (subject to the limitations set forth in Section 2(f))
as soon as practicable, but in any event not later than ten (10) business days after the necessity therefor arises and the Company’s
financial statements as filed with the SEC are current as would be required by such New Registration Statement, subject to any
limits that may be imposed by the SEC pursuant to Rule 415 under the Securities Act. The Company shall use its reasonable best
efforts to cause such amendment and/or New Registration Statement to become effective as soon as practicable following the filing
thereof.

 

    	 	2	 

     

    

 

d.
Piggyback Registration. In the event that
any of the Registrable Securities have not been included in the Initial Registration Statement or a New Registration Statement,
and the Company initially files any other registration statement under the Securities Act (other than on Form S-4, Form S-8, or
with respect to other employee related plans or rights offerings) (an “Other Registration Statement”), then
the Company shall include in such Other Registration Statement first all of such Put Shares that have not been previously Registered,
and second any other securities the Company wishes to include in such Other Registration Statement. The Company agrees that it
shall not file any such Other Registration Statement unless all of the Put Shares have been included in such Other Registration
Statement or otherwise have been Registered for resale as described above; provided, that the Company shall be able to file any
applicable registration statement with respect to any Company underwritten public offering or a public offering via a placement
agent without having to comply with the requirements of this Section 2(d).

 

e.
Effectiveness. The Investor and its counsel
shall have a reasonable opportunity to review and comment upon any Registration Statement and any amendment or supplement to such
Registration Statement and any related prospectus prior to its filing with the SEC, and the Company shall give due consideration
to all reasonable comments. The Investor and its counsel shall use their reasonable best efforts to comment upon any Registration
Statement and any amendment or supplement to such Registration Statement and any related prospectus within two (2) business days
from the date the Investor receives a draft of such filing. The Investor shall furnish all information reasonably requested by
the Company for inclusion therein. The Company shall use reasonable best efforts to keep all Registration Statements effective,
including but not limited to pursuant to Rule 415 promulgated under the Securities Act and available for use by the Investor for
the resale of all of the Registrable Securities covered thereby at all times until the earlier of (i) the date as of which the
Investor may sell all of the Registrable Securities without restriction pursuant to Rule 144 promulgated under the Securities
Act without any restrictions (including any restrictions under Rule 144(c) or Rule 144(i)) and (ii) the date on which the Investor
shall have sold all the Registrable Securities covered thereby and no Put Shares remain issuable under the Purchase Agreement
(the “Registration Period”). Each Registration Statement (including any amendments or supplements thereto and
prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not
misleading.

 

f.
Offering. If the staff of the SEC (the
“Staff”) or the SEC seeks to characterize any offering pursuant to a Registration Statement filed pursuant
to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become or remain
effective and be used for resales by the Investor under Rule 415 at then-prevailing market prices (and not fixed prices) by comment
letter or otherwise, or if after the filing of the Initial Registration Statement with the SEC pursuant to Section 2(a),
the Company is otherwise required by the Staff or the SEC to reduce the number of Registrable Securities included in such initial
Registration Statement, then the Company shall reduce the number of Registrable Securities to be included in such Initial Registration
Statement (in such amounts of specific Registrable Securities as the Investor, the Company and their respective legal counsel
shall mutually agree to be removed therefrom) until such time as the Staff and the SEC shall so permit such Registration Statement
to become effective and be used as aforesaid. In the event of any reduction in Registrable Securities pursuant to this paragraph,
the Company shall file one or more New Registration Statements in accordance with Section 2(c) until such time as all Registrable
Securities have been included in Registration Statements that have been declared effective and the prospectus contained therein
is available for use by the Investor. Notwithstanding any provision herein or in the Purchase Agreement to the contrary, the Company’s
obligations to register Registrable Securities (and any related conditions to the Investor’s obligations) shall be qualified
as necessary to comport with any requirement of the SEC or the Staff as addressed in this Section 2(f).

 

    	 	3	 

     

    

 

g.
Termination of Obligations. The Company’s
obligations under this Agreement shall terminate effective as of the date and time that the Purchase Agreement is terminated pursuant
to the terms thereof, provided that such obligations shall not terminate if the Investor holds Put Shares.

 

3.
RELATED OBLIGATIONS.

 

With
respect to a Registration Statement and whenever any Registrable Securities are to be Registered pursuant to Section 2,
including on any Other Registration Statement, the Company shall use its reasonable best efforts to effect the registration of
the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall
have the following obligations:

 

a.
The Company shall prepare and file with the SEC
such amendments (including post-effective amendments on Form S-1) and supplements to any registration statement and the prospectus
used in connection with such registration statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the
Securities Act, as may be necessary to keep the Registration Statement or any Other Registration Statement effective at all times
during the Registration Period, and, during such period, comply with the provisions of the Securities Act with respect to the
disposition of all Registrable Securities of the Company covered by the Registration Statement or any Other Registration Statement
until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition
by the seller or sellers thereof as set forth in such registration statement.

 

b.
The Company shall permit the Investor to review
and comment upon each Registration Statement or any Other Registration Statement and all amendments and supplements thereto at
least two (2) business days prior to their filing with the SEC, and not file any document in a form to which Investor reasonably
objects with legally supported reasons. The Investor shall use its reasonable best efforts to comment upon the Registration Statement
or any Other Registration Statement and any amendments or supplements thereto within two (2) business days from the date the Investor
receives the substantially final version thereof. The Company shall furnish to the Investor, without charge, and within one (1)
business day, any comments and/or any other correspondence from the SEC or the Staff to the Company or its representatives relating
to the Registration Statement or any Other Registration Statement. The Company shall use its commercially reasonable best efforts
to respond to the SEC or the Staff, as applicable, regarding the resolution of any such comments and/or correspondence as promptly
as practicable.

 

    	 	4	 

     

    

 

c.
Upon request of the Investor, the Company shall
electronically furnish to the Investor, (i) promptly after the same is prepared and filed with the SEC, at least one copy of such
registration statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated
therein by reference and all exhibits, (ii) upon the effectiveness of any registration statement, a copy of the prospectus included
in such registration statement and all amendments and supplements thereto (or such other number of copies as the Investor may
reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Investor may
reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor.
For the avoidance of doubt, any filing available to the Investor via the SEC’s live EDGAR system shall be deemed “furnished
to the Investor” hereunder.

 

d.
The Company shall use reasonable best efforts
to (i) register and qualify the Registrable Securities covered by a registration statement under such other securities or “blue
sky” laws of Puerto Rico and such other jurisdictions in the United States as the Investor reasonably requests, (ii) prepare
and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to any such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other
actions as may be necessary to maintain such registrations and qualifications (including all Registration Statements) in effect
at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the
Registrable Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection
therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required
to qualify but for this Section 3(d), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general
consent to service of process in any such jurisdiction. The Company shall promptly notify the Investor who holds Registrable Securities
of the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of
the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction in the United States
or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

e.
The Company shall, as promptly as practicable,
notify the Investor in writing of the happening of any event or existence of such facts as a result of which the prospectus included
in any registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading, and promptly prepare a supplement or amendment to such registration statement to correct such untrue
statement or omission, and deliver a copy of such supplement or amendment to the Investor (or such other number of copies as the
Investor may reasonably request). The Company shall also promptly notify the Investor in writing (i) when a prospectus or any
prospectus supplement or post-effective amendment has been filed, and when a registration statement or any post-effective amendment
has become effective (notification of such effectiveness shall be delivered to the Investor by email or facsimile on the same
day of such effectiveness and by overnight mail), (ii) of any request by the SEC for amendments or supplements to any registration
statement or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective
amendment to a registration statement would be appropriate.

 

    	 	5	 

     

    

 

f.
The Company shall use its reasonable best efforts
to prevent the issuance of any stop order or other suspension of effectiveness of any registration statement, or the suspension
of the qualification of any Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued,
to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify the Investor of the issuance
of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such
purpose. In addition, if the Company shall receive any comment letter from the SEC relating to any Registration Statement under
which Registrable Securities are Registered, the Company shall notify the Investor of the issuance of such letter and use its
reasonable best efforts to address such comments in a manner satisfactory to the SEC.

 

g.
The Company shall (i) cause all the Registrable
Securities to be listed on each United States securities exchange on which securities of the same class or series issued by the
Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange,
or (ii) secure designation and quotation of all the Registrable Securities on the Principal Market. The Company shall pay all
fees and expenses in connection with satisfying its obligation under this Section.

 

h.
To the extent that the Company’s securities
are eligible to be treated as DWAC Shares at the time of the Execution Date, the Company shall cooperate with the Investor to
facilitate the timely preparation and delivery of DWAC Shares representing the Registrable Securities to be offered pursuant to
any Registration Statement. “DWAC Shares” means shares of Common Stock that are (i) issued in electronic form,
(ii) freely tradable and transferable and without restriction on resale and (iii) timely credited by the Transfer Agent to the
Investor’s or its designee’s specified DWAC account with The Depository Trust Company (“DTC”) under
the DTC/FAST Program, or any similar program hereafter adopted by DTC performing substantially the same function.

 

i.
The Company shall at all times maintain the services
of its Transfer Agent and registrar with respect to its Common Stock, subject to the Company’s ability to change its Transfer
Agent in accordance with the terms of the Purchase Agreement.

 

j.
If reasonably requested by the Investor, the
Company shall (i) immediately incorporate in a prospectus supplement or post-effective amendment such information as the Investor
believes should be included therein relating to the sale and distribution of Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being sold, the purchase price being paid therefor and any other
terms of the offering of the Registrable Securities; (ii) make all required filings of such prospectus supplement or post-effective
amendment as soon as practicable upon notification of the matters to be incorporated in such prospectus supplement or post-effective
amendment; and (iii) supplement or make amendments to any Registration Statement.

 

    	 	6	 

     

    

 

k.
The Company shall use its commercial reasonable
best efforts to cause the Registrable Securities covered by any Registration Statement to be Registered with or approved by such
other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.

 

l.
Within one (1) business day after any Registration
Statement which includes Registrable Securities is ordered effective by the SEC, or any prospectus supplement or post-effective
amendment including Registrable Securities is filed with the SEC, the Company shall deliver, and shall cause legal counsel for
the Company to deliver, to the Transfer Agent for such Registrable Securities (with copies to the Investor) confirmation that
such Registration Statement has been declared effective by the SEC in the form attached hereto as Exhibit A. Thereafter,
if requested by the Investor at any time, the Company shall require its counsel to deliver to the Investor a written confirmation
(based on such counsel’s confirmation from the Company) whether or not (i) the effectiveness of such Registration Statement
has lapsed at any time for any reason (including, without limitation, the issuance of a stop order), (ii) any comment letter applicable
to the Registration Statement has been issued by the SEC, and (iii) whether or not the Registration Statement is current and available
to the Investor for sale of all of the Registrable Securities.

 

m.
The Company shall take all other reasonable actions
necessary to expedite and facilitate disposition by the Investor of Registrable Securities pursuant to any Registration Statement,
subject to the terms of the Purchase Agreement.

 

4.
OBLIGATIONS OF THE INVESTOR.

 

a.
The Company shall notify the Investor in writing
of the information the Company reasonably requires from the Investor in connection with any Registration Statement hereunder.
The Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended
method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the Registration of such
Registrable Securities and shall execute such documents in connection with such Registration as the Company may reasonably request.
The Company shall use its commercial reasonable best efforts to have the “Selling Stockholder” and “Plan of
Distribution” sections of the Registration Statement reflect the language substantially in the form timely provided to the
Company by the Investor.

 

b.
The Investor agrees to cooperate with the Company
as reasonably requested by the Company in connection with the preparation and filing of any Registration Statement hereunder.

 

c.
The Investor agrees that, upon receipt of any
notice from the Company of the happening of any event or existence of facts of the kind described in Section 3(f) or the
first sentence of 3(e), the Investor will immediately discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until withdrawal of a stop order contemplated by Section 3(f)
or the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 3(e).
Notwithstanding anything to the contrary, the Company shall cause its Transfer Agent to promptly issue DWAC Shares in accordance
with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor
has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of the happening of any
event of the kind described in Section 3(f) or the first sentence of Section 3(e) and for which the Investor has
not yet settled.

 

5.
EXPENSES OF REGISTRATION.

 

All
reasonable expenses, other than sales or brokerage commissions, incurred in connection with registrations, filings or qualifications
pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees,
printers and accounting fees, and fees and disbursements of counsel for the Company, shall be paid by the Company. For the avoidance
of doubt, subject to Section 10.8 of the Purchase Agreement, the Company shall not be responsible in any way for the costs or
expenses of the Investor’s legal and accounting professionals incurred in connection with this Agreement, the other Transaction
Documents, any Registration Statement or any document or filing related thereto.

 

    	 	7	 

     

    

 

6.
INDEMNIFICATION.

 

a.
To the fullest extent permitted by law, the Company
will, and hereby agrees to, indemnify, hold harmless and defend the Investor, each Person, if any, who controls or is under common
control with the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor
and each Person, if any, who is an “affiliate” of the Investor within the meaning of the Securities Act or the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) (each, an “Indemnified Person”), against
any losses, claims, damages, liabilities, judgments, fines, penalties, charges, costs, attorneys’ fees, amounts paid in
settlement or expenses, joint or several, (collectively, “Claims”), incurred in investigating, preparing or
defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court
or governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an
Indemnified Person is or may be a party thereto (“Indemnified Damages”), to which any of them may become subject
insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based
upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement, any Other Registration
Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under
the securities or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered, provided
that the location of such jurisdictions have been communicated to the Company in writing in advance of such qualification (“Blue
Sky Filing”), or the omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained
in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the
SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in
light of the circumstances under which the statements therein were made, not misleading, (iii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act, any other law, including, without limitation, any state securities law,
or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement
or any Other Registration Statement or (iv) any material violation by the Company of this Agreement (the matters in the foregoing
clauses (i) through (iv) being, collectively, “Violations”). The Company shall reimburse each Indemnified Person
promptly as such expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred
by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein,
the indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified Person arising
out of or based upon a Violation which occurs in reliance upon and in conformity with information about the Investor furnished
in writing to the Company by such Indemnified Person expressly for use in connection with the preparation of a Registration Statement,
any Other Registration Statement or any such amendment thereof or supplement or prospectus thereto, if such prospectus was timely
made available by the Company pursuant to Section 3(c) or Section 3(e); (ii) with respect to any superseded prospectus,
shall not inure to the benefit of any such person from whom the person asserting any such Claim purchased the Registrable Securities
that are the subject thereof (or to the benefit of any person controlling such person) if the untrue statement or omission of
material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented,
if such revised prospectus was timely made available by the Company pursuant to Section 3(c) or Section 3(e), and
the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to a violation
and such Indemnified Person, notwithstanding such advice, used it; (iii) shall not be available to the extent such Claim is based
on a failure of the Investor to deliver or to cause to be delivered the prospectus made available by the Company, if such prospectus
was timely made available by the Company pursuant to Section 3(c) or Section 3(e); (iv) shall not apply to amounts
paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent
shall not be unreasonably withheld; and (v) with respect to any Claim that results primarily from the Indemnified Person’s
failure to perform any covenant or agreement contained in this Agreement or the Indemnified Person’s negligence, recklessness,
fraud, willful misconduct or bad faith in performing its obligations under this Agreement. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer
of the Registrable Securities by the Investor pursuant to Section 9.

 

    	 	8	 

     

    

 

b.
Promptly after receipt by an Indemnified Person
under this Section 6 of notice of the commencement of any action or proceeding (including any governmental action or proceeding)
involving a Claim, such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this Section
6, deliver to the Company a written notice of the commencement thereof, and the Company shall have the right to participate
in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to
the Company and the Indemnified Person; provided, however, that an Indemnified Person shall have the right to retain its own counsel
with the fees and expenses to be paid by the Company, if, in the reasonable opinion of counsel retained by the Company, the representation
by such counsel of the Indemnified Person and the Company would be inappropriate due to actual or potential differing interests
between such Indemnified Person and any other party represented by such counsel in such proceeding. The Indemnified Person shall
cooperate fully with the Company in connection with any negotiation or defense of any such action or Claim by the Company and
shall furnish to the Company all information reasonably available to the Indemnified Person which relates to such action or Claim.
The indemnifying party shall keep the Indemnified Person fully apprised at all times as to the status of the defense or any settlement
negotiations with respect thereto. The Company shall not be liable for any settlement of any action, Claim or proceeding effectuated
without its written consent, provided, however, that the Company shall not unreasonably withhold, delay or condition its consent.
The Company shall not, without the consent of the Indemnified Person, consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified
Person of a release from all liability in respect to such Claim or litigation. Following indemnification as provided for hereunder,
the Company shall be subrogated to all rights of the Indemnified Person with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The failure to deliver written notice to the Company within a
reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person
under this Section 6, except to the extent that the Company is prejudiced in its ability to defend such action.

 

c.
The indemnification required by this Section
6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when
bills are received or Indemnified Damages are incurred.

 

d.
The indemnity agreements contained herein shall
be in addition to (i) any cause of action or similar right of the Indemnified Person against the Company or others, and (ii) any
liabilities the Company may be subject to pursuant to the law.

 

7.
CONTRIBUTION.

 

To
the extent any indemnification by the Company is prohibited or limited by law, the Company agrees to make the maximum contribution
with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from the Company or any seller of Registrable Securities
who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited
in amount to the net amount of proceeds received by such seller from the sale of such Registrable Securities.

 

8.
REPORTS AND DISCLOSURE UNDER THE SECURITIES
ACTS.

 

With
a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar
rule or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without
registration (“Rule 144”), the Company agrees, at the Company’s sole expense, to:

 

a.
make and keep “current public information”
available, as such term is understood and defined in Rule 144;

 

b. file
with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the
Exchange Act so long as the Company remains subject to such requirements and the filing of such reports and other documents
is required for the applicable provisions of Rule 144;

 

    	 	9	 

     

    

 

c.
electronically furnish to the Investor so long
as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company that it has complied
with the reporting and or disclosure provisions of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of the most
recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such
other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration;
and

 

d.
take such additional action as is reasonably
requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to Rule 144, including, without limitation,
delivering all such legal opinions, consents, certificates, resolutions and instructions to the Company’s Transfer Agent
as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with Investor and Investor’s
broker to effect such sale of securities pursuant to Rule 144; provided, that that the Company shall not be required to provide
any legal opinions other than in connection with a Registration Statement, New Registration Statement or Other Registration Statement,
unless such opinions are paid for by the Investor.

 

The
Company agrees that damages may be an inadequate remedy for any breach of the terms and provisions of this Section 8 and
that Investor shall, whether or not it is pursuing any remedies at law, be entitled to equitable relief in the form of a preliminary
or permanent injunctions, without having to post any bond or other security, upon any breach or threatened breach of any such
terms or provisions.

 

9.
ASSIGNMENT OF REGISTRATION RIGHTS.

 

The
Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Buyer,
or any Investor as assignee pursuant to this Section 9. The Buyer, or any Investor, may not assign its rights under this
Agreement without the prior written consent of the Company other than to an affiliate of such Investor.

 

10.
AMENDMENT OF REGISTRATION RIGHTS.

 

No
provision of this Agreement may be amended or waived by the parties from and after the date that is one Business Day immediately
preceding the initial filing of the Initial Registration Statement with the SEC. Subject to the immediately preceding sentence,
no provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived
other than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party
to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall
not operate as a waiver thereof.

 

    	 	10	 

     

    

 

11.
MISCELLANEOUS.

 

a.
A Person is deemed to be a holder of Registrable
Securities whenever such Person owns or is deemed to own of record such Registrable Securities. If the Company receives conflicting
instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company shall
act upon the basis of instructions, notice or election received from the registered owner of such Registrable Securities.

 

b.
Any notices, consents, waivers or other communications
required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered:
(i) upon receipt, when delivered personally; (ii) upon receipt, when sent by email (provided confirmation of transmission is mechanically
or electronically generated and kept on file by the sending party) if delivered on a business day during normal business hours
where such notice is to be received, or the first business day following such delivery (if delivered other than on a business
day during normal business hours where such notice is to be received); or (iii) three (3) business day after timely deposit with
a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses
for such communications shall be:

 

If
to the Company:

 

Propanc
Biopharma, Inc.

302,
6 Butler Street

Camberwell,
VIC, 3124 Australia

Email:
(at such email address separately provided to the Investor)

Attention:
James Nathanielsz, Chief Executive Officer

 

with
a copy to (that shall not constitute notice)

 

Foley
Shechter Ablovatskiy LLP

211
East 43rd Street, Seventh Floor

New
York, NY 10017

E-mail:
js@foleyshechter.com

Attention:
Jonathan Shechter, Esq.

 

If
to the Investor:

 

Oasis
Capital, LLC

208
Ponce de Leon Ave, Suite 1600

San
Juan, PR 00918

E-mail:
adam@oasis-cap.com

Attention:
Adam R. Long, Managing Partner

 

with
a copy (that shall not constitute notice) to:

 

K&L
Gates LLP

200
S. Biscayne Blvd., Suite 3900

Miami,
FL 33131

E-mail:
john.owens@klgates.com

Attention:
John D. Owens, III, Esq.

 

    	 	11	 

     

    

 

or
at such other address and/or email address and/or to the attention of such other person as the recipient party has specified by
written notice given to each other party three (3) business days prior to the effectiveness of such change. Written confirmation
of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s email account containing the time, date, recipient email address, as applicable, and an image
of the first page of such transmission or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable
evidence of personal service, receipt by email or receipt from a nationally recognized overnight delivery service in accordance
with clause (i), (ii) or (iii) above, respectively.

 

c.
All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of Kansas, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of Kansas or any other jurisdictions) that
would cause the application of the laws of any jurisdictions other than the State of Kansas.

 

d.
 Any disputes, Claims, or controversies hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein shall be referred to and resolved solely
and exclusively by binding arbitration to be conducted before the Judicial Arbitration and Mediation Service (“JAMS”),
or its successor pursuant the expedited procedures set forth in the JAMS Comprehensive Arbitration Rules and Procedures (the “Rules”),
including Rules 16.1 and 16.2 of those Rules. The arbitration shall be held in New York, New York, before a tribunal consisting
of one (1) arbitrator who will be selected in accordance with the “strike and rank” methodology set forth in Rule
15. Either party to this Agreement may, without waiving any remedy under this Agreement, seek from any federal or state court
sitting in the City of New York, NY any interim or provisional relief that is necessary to protect the rights or property of that
party, pending the establishment of the arbitral tribunal. The costs and expenses of such arbitration shall be paid by and be
the sole responsibility of the Company, including but not limited to the Investor’s attorneys’ fees and each arbitrator’s
fees. The arbitrators’ decision must set forth a reasoned basis for any award of damages or finding of liability. The arbitrator’s
decision and award will be made and delivered as soon as reasonably possibly and in any case within sixty (60) days’ following
the conclusion of the arbitration hearing and shall be final and binding on the parties and may be entered by any court having
jurisdiction thereof.

 

e.
If any provision of this Agreement shall be invalid
or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other
jurisdiction.

 

f.
EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT
IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    	 	12	 

     

    

 

g.
This Agreement and the Purchase Agreement constitute
the entire agreement among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions,
promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement and the Purchase
Agreement supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof
and thereof.

 

h.
Subject to the requirements of Section 9,
this Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties hereto.

 

i.
The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect the meaning hereof.

 

j.
This Agreement may be executed in identical counterparts,
each of which shall be deemed an original but all of which shall constitute one and the same agreement. This Agreement, once executed
by a party, may be delivered to the other party hereto by facsimile transmission or by e-mail in a “.pdf” format data
file of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

 

k.
Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates,
instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes
of this Agreement and the consummation of the transactions contemplated hereby.

 

l.
The language used in this Agreement will be deemed
to be the language chosen by the parties to express their mutual intent and no rules of strict construction will be applied against
any party.

 

m.
This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns, and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person.

 

*
* * * * *

 

    	 	13	 

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the Execution Date.

 

	 	THE
    COMPANY:
	 	 
	 	PROPANC
    BIOPHARMA, INC.
	 	 
	 	By:
	/s/
    James Nathanielsz
	 	Name:
    	James
    Nathanielsz
	 	Title:
    	Chief
    Executive Officer
	 	 	 
	 	BUYER:
	 	 
	 	OASIS
    CAPITAL, LLC
	 	 
	 	By:
    	/s/
    Adam R. Long
	 	Name:
    	Adam
    R. Long
	 	Title:
    	Managing
    Partner

 

    	 	 	 

     

    

 

EXHIBIT
A

 

TO
REGISTRATION RIGHTS AGREEMENT

 

FORM
OF NOTICE OF EFFECTIVENESS

OF
REGISTRATION STATEMENT

 

______,
2019

 

Corporate
Stock Transfer, Inc.

3200
Cherry Creek South Drive

Suite
430

Denver,
CO 80209

 

Re:
EFFECTIVENESS OF REGISTRATION STATEMENT

 

Ladies
and Gentlemen:

 

We
are counsel to PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and have represented
the Company in connection with that certain Equity Purchase Agreement, dated as of February 25, 2019 (the “Purchase Agreement”),
entered into by and between the Company and Oasis Capital, LLC (the “Buyer”) pursuant to which the Company
has agreed to issue to the Buyer shares of the Company’s Common Stock, $0.001 par value (the “Common Stock”),
in an amount up to Ten Million Dollars ($10,000,000.00) (the “Put Shares”), in accordance with the terms of
the Purchase Agreement. In connection with the transactions contemplated by the Purchase Agreement, the Company has registered
with the U.S. Securities and Exchange Commission the following shares of Common Stock:

 

		(1)	_________Put
                                         Shares to be issued to the Buyer upon purchase from the Company by the Buyer from time
                                         to time in accordance with the Purchase Agreement.

Pursuant
to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, of even date with the Purchase Agreement
with the Buyer (the “Registration Rights Agreement”) pursuant to which the Company agreed, among other things,
to register the Put Shares under the Securities Act of 1933, as amended (the “Securities Act”). In connection
with the Company’s obligations under the Purchase Agreement and the Registration Rights Agreement, on [______________], 2019,
the Company filed a Registration Statement (File No. 333-[_________________]) (the “Registration Statement”) with
the Securities and Exchange Commission (the “SEC”) relating to the resale of the Put Shares.

 

In
connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has
entered an order declaring the Registration Statement effective under the Securities Act at [_______] [A.M./P.M.] on [____],
2019, and we have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that any stop order suspending
its effectiveness has been issued or that any proceedings for that purpose are pending before, or threatened by, the SEC, and
the Put Shares are available for resale under the Securities Act pursuant to the Registration Statement and may be issued without
any restrictive legend.

 

    	 	 	 

     

    

 

	 	Very
    truly yours,
	 	[Company
    Counsel]
	 	 
	 	By:	             

 

	cc:	Oasis
    Capital, LLCExhibit

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Execution Version

Exhibit 10.20

SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

THIS SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of November 29, 2018 (the “Seventh Amendment Effective Date”), is made among GenMark Diagnostics, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties party to that certain Loan and Security Agreement (as defined below), Solar Senior Capital Ltd., in its capacity as administrative and collateral agent (in such capacity, together with its successors and assigns in such capacity, “Agent”) and lender, Solar Capital Ltd., as lender, SUNS SPV LLC, as lender, SCP Private Credit Income Fund SPV LLC, as lender, SCP Private Credit Income Fund LP, as lender, and the other Lenders party to the Loan and Security Agreement or otherwise a party thereto from time to time (each a “Lender” and collectively, the “Lenders”).
The Borrower, the other Loan Parties, the Lenders and Agent are parties to a Loan and Security Agreement dated as of January 12, 2015 (as amended by that certain letter agreement dated as of September 30, 2015, that certain letter agreement dated as of March 17, 2016, that certain First Amendment to Loan and Security Agreement dated as of July 27, 2016, that certain Second Amendment to Loan and Security Agreement dated as of February 27, 2017, that certain Third Amendment to Loan and Security Agreement and Second Amendment to Fee Letter dated as of May 31, 2017 (the “Third Amendment”), that certain Fourth Amendment to Loan and Security Agreement and Third Amendment to Fee Letter, dated as of June 7, 2017 (the “Fourth Amendment”), that certain Fifth Amendment to Loan and Security Agreement and Fourth Amendment to Fee Letter, dated as of December 13, 2017 (the “Fifth Amendment”), that certain Sixth Amendment to Loan and Security Agreement and Fifth Amendment to Fee Letter, dated as of September 28, 2018 (the “Sixth Amendment”), and as further amended, amended and restated, supplemented or otherwise modified from time to time, the “Loan and Security Agreement”).  The Borrower has requested that the Lenders agree to certain amendments to the Loan and Security Agreement.  The Lenders have agreed to such request, subject to the terms and conditions hereof.
Accordingly, the parties hereto agree as follows:
SECTION 1   Definitions; Interpretation.
(a)    Terms Defined in Loan and Security Agreement.  All capitalized terms used in this Amendment (including in the preamble and recitals hereof) and not otherwise defined herein shall have the meanings assigned to them in the Loan and Security Agreement.
(b)    Interpretation.  The rules of interpretation set forth in Section 1.1 of the Loan and Security Agreement shall be applicable to this Amendment and are incorporated herein by this reference.
SECTION 2   Amendments to the Loan and Security Agreement.  
(a)    The Loan and Security Agreement shall be amended as follows effective as of the Seventh Amendment Effective Date:

1

(i)    Section 2.1(a).  Section 2.1(a)(iv-vi) shall be amended and restated as follows, with a new Section 2.1(a)(vii) added as follows:
“(iv)    Subject to the terms and conditions of this Agreement and in reliance upon the representations and warranties of the Loan Parties contained herein, each Lender with a Term Loan D Commitment severally and not jointly agrees to make a loan (the “Term Loan D”) in Dollars to Borrower on the Sixth Amendment Effective Date, in an amount equal to such Lender's Term Loan D Commitment.
(v)    Subject to the terms and conditions of this Agreement and in reliance upon the representations and warranties of the Loan Parties contained herein, each Lender with a Term Loan E Commitment severally and not jointly agrees to make a loan (the “Term Loan E”, and together with the Term Loan A, Term Loan B, Term Loan C, and Term Loan D, each a “Term Loan” and collectively, the “Term Loans”) in Dollars to Borrower on the Seventh Amendment Effective Date, in an amount equal to such Lender's Term Loan E Commitment.
(vi)    Once a Term Loan is repaid or prepaid, it cannot be reborrowed.
(vii)    Each Term Loan made by each Lender is evidenced by this Agreement, and if requested by such Lender, a Note payable to such Lender.”
(ii)    Section 2.6(b).  Section 2.6(b) shall be amended by replacing the table of Final Payment Fee appearing therein with the following: 
	
		
	Lender
	Final Payment Fee

	Solar Capital Ltd.
	***

	Solar Senior Capital Ltd.
	***

	SUNS SPV LLC
	***

	SCP Private Credit Income Fund SPV LLC
	***

	Aggregate Final Payment Fee
	***

(iii)    Section 11.  The following definitions are added to Section 11 in their proper alphabetical order:
“Seventh Amendment Effective Date” means November 29, 2018.

2

“Term Loan E Commitment” means, with respect to each Lender, the amount set forth opposite such Lender’s name on Schedule A hereto under the caption “Term Loan E Commitment”, as amended from time to time to reflect any permitted assignments and as such amount may be reduced or terminated pursuant to this Agreement.  “Term Loan E Commitments” means the Term Loan E Commitments of all Lenders with a Term Loan E Commitment.
(iv)    Section 11.  The following definitions shall be amended and restated as follows:
“Term Loan Commitment” or “Term Loan Commitments” means the Term Loan A Commitments, the Term Loan B Commitments, the Term Loan C Commitments, the Term Loan D Commitments, and the Term Loan E Commitments.
(v)    Schedule A.  Schedule A of the Loan and Security Agreement, the Schedule of Lenders and Commitments, shall be amended and restated in its entirety with Schedule 1 attached hereto.
(vi)    Schedule B.  Schedule B of the Loan and Security Agreement, the Term Loan Principal Payment Schedule, shall be amended and restated in its entirety with Schedule 2 hereto attached hereto.
(b)    References Within Loan and Security Agreement.  Each reference in the Loan and Security Agreement to “this Agreement” and the words “hereof,” “herein,” “hereunder,” or words of like import, shall mean and be a reference to the Loan and Security Agreement as amended by this Amendment.
SECTION 3   Conditions of Effectiveness.  The effectiveness of Section 2 of this Amendment shall be subject to the satisfaction of each of the following conditions precedent:
(a)    Fees and Expenses.  The Borrower shall have paid (i)  all invoiced costs and expenses then due in accordance with Section 5(d), and (ii) all other fees, costs and expenses, if any, due and payable as of the Seventh Amendment Effective Date under the Loan and Security Agreement.
(b)    This Amendment.  Agent shall have received this Amendment, executed by Agent, the Lenders and the Loan Parties.
(c)    Representations and Warranties; No Default.  On the Seventh Amendment Effective Date, after giving effect to the amendment of the Loan and Security Agreement contemplated hereby: 
(i)    The representations and warranties contained in Section 4 shall be true and correct on and as of the Seventh Amendment Effective Date as though made on and as of such date; and

3

(ii)    There exist no Defaults or Events of Default.
SECTION 4    Representations and Warranties.  To induce the Lenders to enter into this Amendment, each Loan Party hereby confirms, as of the date hereof, (a) that the representations and warranties made by it in Section 5 of the Loan and Security Agreement and in the other Loan Documents are true and correct in all material respects; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; (b) that there has not been and there does not exist a Material Adverse Effect; and (c) that other than as updated by Exhibit B attached to the Third Amendment, Exhibit A attached to the Fifth Amendment and Exhibit B attached to the Sixth Amendment, the information included in the Perfection Certificate delivered to Agent on June 7, 2016 remains true and correct.  For the purposes of this Section 4, (i) each reference in Section 5 of the Loan and Security Agreement to “this Agreement,” and the words “hereof,” “herein,” “hereunder,” or words of like import in such Section, shall mean and be a reference to the Loan and Security Agreement as amended by this Amendment, and (ii) any representations and warranties which relate solely to an earlier date shall not be deemed confirmed and restated as of the date hereof (provided that such representations and warranties shall be true, correct and complete as of such earlier date).
SECTION 5    Miscellaneous.
(a)    Loan Documents Otherwise Not Affected; Reaffirmation.  Except as expressly amended pursuant hereto or referenced herein, the Loan and Security Agreement and the other Loan Documents shall remain unchanged and in full force and effect and are hereby ratified and confirmed in all respects.  The Lenders’ and Agent’s execution and delivery of, or acceptance of, this Amendment shall not be deemed to create a course of dealing or otherwise create any express or implied duty by any of them to provide any other or further amendments, consents or waivers in the future.  Each Loan Party hereby reaffirms the grant of security under Section 3.1 of the Loan and Security Agreement and hereby reaffirms that such grant of security in the Collateral secures all Obligations under the Loan and Security Agreement and all Guaranteed Obligations (as defined in the Guaranty), as applicable, including without limitation any Term Loans funded on or after the Seventh Amendment Effective Date, as of the date hereof.
(b)    Conditions.  For purposes of determining compliance with the conditions specified in Section 3, each Lender that has signed this Amendment shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless Agent shall have received notice from such Lender prior to the Seventh Amendment Effective Date specifying its objection thereto.
(c)    No Reliance.  Each Loan Party hereby acknowledges and confirms to Agent and the Lenders that such Loan Party is executing this Amendment on the basis of its own investigation and for its own reasons without reliance upon any agreement, representation, understanding or communication by or on behalf of any other Person.

4

(d)    Costs and Expenses.  The Borrower agrees to pay to Agent within ten (10) days of its receipt of an invoice (or on the Seventh Amendment Effective Date to the extent invoiced on or prior to the Seventh Amendment Effective Date), the reasonable, documented, out-of-pocket costs and expenses of Agent and the Lenders party hereto, and the reasonable, documented, fees and disbursements of counsel to Agent and the Lenders party hereto, in connection with the negotiation, preparation, execution and delivery of this Amendment and any other documents to be delivered in connection herewith on the Seventh Amendment Effective Date or after such date.
(e)    Binding Effect.  This Amendment binds and is for the benefit of the successors and permitted assigns of each party.  
(f)    Governing Law.  THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL IN ALL RESPECTS BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE, REGARDLESS OF THE LOCATION OF THE COLLATERAL, PROVIDED, HOWEVER, THAT IF THE LAWS OF ANY JURISDICTION OTHER THAN NEW YORK SHALL GOVERN IN REGARD TO THE VALIDITY PERFECTION OR EFFECT OF PERFECTION OF ANY LIEN OR IN REGARD TO PROCEDURAL MATTERS AFFECTING ENFORCEMENT OF ANY LIENS IN COLLATERAL, SUCH LAWS OF SUCH OTHER JURISDICTIONS SHALL CONTINUE TO APPLY TO THAT EXTENT. 
(g)    Complete Agreement; Amendments.  This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements with respect to such subject matter.  All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.  
(h)    Severability of Provisions.  Each provision of this Amendment is severable from every other provision in determining the enforceability of any provision.
(i)    Counterparts.  This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Amendment.  Delivery of an executed counterpart of a signature page of this Amendment by facsimile, portable document format (.pdf) or other electronic transmission will be as effective as delivery of a manually executed counterpart hereof.
(j)    Loan Documents. This Amendment and the documents related hereto shall constitute Loan Documents.
[Balance of Page Intentionally Left Blank; Signature Pages Follow] 

5

IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment, as of the date first above written.
BORROWER:

GENMARK DIAGNOSTICS, INC., 
as Borrower

By: /s/ Scott Mendel
Title: Chief Financial Officer

GUARANTORS:

CLINICAL MICRO SENSORS, INC., 
as Guarantor

By: /s/ Scott Mendel
Title: Chief Financial Officer

OSMETECH INC., 
as Guarantor

By: /s/ Scott Mendel
Title: Chief Financial Officer

[Signature Page to Seventh Amendment to Loan and Security Agreement]

AGENT:

SOLAR SENIOR CAPITAL LTD., 
as Agent and Lender

By: /s/ Richard L Peteka
Name: Richard L Peteka
Title: CFO

[Signature Page to Seventh Amendment to Loan and Security Agreement]

LENDERS:

SOLAR CAPITAL LTD., 
as Lender

By: /s/ Richard L Peteka
Name: Richard L Peteka
Title: CFO

SUNS SPV LLC, 
as Lender

By: /s/ Richard L Peteka
Name: Richard L Peteka
Title: CFO

SCP PRIVATE CREDIT INCOME FUND SPV LLC, 
as Lender

By: /s/ Richard L Peteka
Name: Richard L Peteka
Title: CFO

SCP PRIVATE CREDIT INCOME FUND LP, 
as Lender

By: /s/ Richard L Peteka
Name: Richard L Peteka
Title: CFO

[Signature Page to Seventh Amendment to Loan and Security Agreement]

SCHEDULE 1

SCHEDULE A TO LOAN AND SECURITY AGREEMENT
 
COMMITMENTS AS OF THE SEVENTH AMENDMENT EFFECTIVE DATE

	
															
	Name of Lender
	Term Loan A Commitments
	Pro Rata Share of Term Loan A Commitments
	Term Loan B Commitments
	Pro Rata Share of Term Loan B Commitments
	Term Loan C Commitments
	Pro Rata Share of Term Loan C Commitments
	Term Loan D Commitments
	Pro Rata Share of Term Loan D Commitments
	Term Loan E Commitments
	Pro Rata Share of Term Loan E Commitments
	Revolving Loan Commitments
	Pro Rata Share of Revolving Loan Commitment
	Total Commitments
	Pro Rata Share of Total Commitments

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***
	***

SCHEDULE 2

SCHEDULE B TO LOAN AND SECURITY AGREEMENT

TERM LOAN PRINCIPAL PAYMENT SCHEDULE

	
		
	Scheduled Payment Date
	Amount

	January 1, 2020
	$1,458,333.33

	February 1, 2020
	$1,458,333.33

	March 1, 2020
	$1,458,333.33

	April 1, 2020
	$1,458,333.33

	May 1, 2020
	$1,458,333.33

	June 1, 2020
	$1,458,333.33

	July 1, 2020
	$1,458,333.33

	August 1, 2020
	$1,458,333.33

	September 1, 2020
	$1,458,333.33

	October 1, 2020
	$1,458,333.33

	November 1, 2020
	$1,458,333.33

	December 1, 2020
	$1,458,333.33

	January 1, 2021
	$17,500,000.04

	Total
	$35,000,000.00

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]